Generic Prescription Pharmaceuticals


Perrigo Gets Patent Challenge For Generic Axiron, FDA Approval For Generic Sanctura XR

Perrigo Co. (Nasdaq: PRGO) announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for testosterone topical solution, the generic version of Axiron Topical Solution.

WWJ Newsradio 950–05/29/2013


Perrigo Confirms Settlement Of Generic Version Of Ofirmev Injection Patent Litigation

Allegan-based Perrigo Co. (Nasdaq: PRGO) announced that it has agreed to settle its Hatch-Waxman litigation relating to Ofirmev (acetaminophen) injection brought by Cadence Pharmaceuticals Inc.

WWJ Newsradio 950–11/28/2012